Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (16 items missing)
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Sales
8,381
5,220
5,741
6,502
6,472
6,091
6,121
5,387
Cost of sales
7,056
3,850
4,124
4,890
4,813
4,304
4,605
3,814
Gross Profit
0
0
0
1,612
1,659
1,787
1,516
1,573
Selling, general and administrative expense
1,118
1,399
1,338
1,451
1,327
670
1,358
1,028
Research and development expense
48
96
78
80
104
142
114
110
Total costs and expenses
8,222
5,345
5,540
0
0
0
0
0
Equity and other income - Note D
54
34
48
49
53
64
2
23
Operating Income
213
-91
249
130
281
1,039
46
458
Net interest and other financing expense - Note I
-28
205
197
121
317
282
166
174
Other expense
0
86
-2
1
0
0
0
0
Net gain (loss) on divestitures - Note B
20
59
21
-5
-7
-8
4
-115
Income (loss) from continuing operations before income taxes
261
-323
75
3
-43
749
-116
169
Income tax expense (benefit) - Note L
86
-83
-13
-53
-57
196
-188
-22
Income from continuing operations
175
-240
88
56
14
553
72
191
Income from discontinued operations (net of tax) - Note C
-8
-21
53
358
12
130
161
118
Net income
167
-261
141
414
26
683
233
309
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 19, 2012 n/a
calculated values,
restated on Nov 27, 2013 n/a
calculated values,
restated on Nov 24, 2014 n/a
calculated values,
restated on Nov 20, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (45 items missing)
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
352
417
737
523
346
1,393
1,257
Accounts receivable
n/a
1,392
1,115
1,482
1,481
1,113
1,202
961
Inventories - Note A
n/a
527
447
925
1,008
758
765
706
Deferred income taxes - Note L
n/a
118
112
163
116
107
118
0
Other assets
n/a
48
49
80
81
62
83
169
Held for sale - Note B
n/a
41
693
0
0
487
0
0
Total current assets
n/a
2,478
2,833
3,387
3,209
2,873
3,561
3,093
Auction rate securities - Note G
n/a
170
0
0
0
0
0
0
Cost
n/a
3,459
3,109
4,306
4,478
4,181
4,275
4,144
Accumulated Depreciation
n/a
-1,392
-1,271
-1,392
1,646
1,674
1,861
1,962
Net property, plant and equipment
n/a
2,067
1,838
2,914
2,832
2,507
2,414
2,182
Goodwill - Note H
n/a
2,220
2,148
3,291
3,342
2,709
2,643
2,486
Intangibles - Note H
n/a
1,181
1,111
2,134
1,936
1,437
1,309
1,142
Restricted investments - Note F
n/a
0
0
0
0
0
0
285
Asbestos insurance receivable - Note N
n/a
510
459
448
449
437
433
180
Equity and other unconsolidated investments - Note D
n/a
0
0
193
217
213
81
65
Deferred income taxes
n/a
310
335
0
0
0
0
212
Other assets - Note J
n/a
619
536
599
539
552
479
409
Held for sale - Note B
n/a
52
270
0
0
1,360
0
0
Total noncurrent assets
n/a
5,062
4,859
6,665
9,315
9,215
7,359
6,961
Land
n/a
289
0
0
0
0
0
0
Buildings and Improvements, Gross
n/a
723
0
0
0
0
0
0
Machinery and Equipment, Gross
n/a
2,283
0
0
0
0
0
0
Construction in progress
n/a
164
0
0
0
0
0
0
Total assets
n/a
9,607
9,530
12,966
12,524
12,088
10,920
10,054
Liabilities and owners' equity
Short-term debt - Note I
n/a
23 23000000
71 71000000
83 83000000
344 344000000
308 308000000
329 329000000
326 326000000
Current portion of long-term debt - Note I
n/a
53 53000000
45 45000000
101 101000000
115 115000000
12 12000000
9 9000000
55 55000000
Trade and other payables
n/a
973 973000000
727 727000000
911 911000000
877 877000000
714 714000000
674 674000000
573 573000000
Accrued expenses and other liabilities
n/a
523 523000000
523 523000000
644 644000000
577 577000000
499 499000000
675 675000000
488 488000000
Held for sale - Note B
n/a
5 5000000
321 321000000
0 0
0 0
194 194000000
0 0
0 0
Total current liabilities
n/a
1,577 1577000000
1,687 1687000000
1,739 1739000000
1,913 1913000000
1,727 1727000000
1,687 1687000000
1,442 1442000000
Long-term debt - Note I
n/a
1,537 1537000000
1,108 1108000000
3,648 3648000000
3,131 3131000000
2,947 2947000000
2,911 2911000000
3,348 3348000000
Employee benefit obligations - Note M
n/a
1,214 1214000000
1,367 1367000000
1,566 1566000000
1,839 1839000000
1,110 1110000000
1,468 1468000000
1,076 1076000000
Asbestos litigation reserve - Note N
n/a
956 956000000
841 841000000
783 783000000
771 771000000
735 735000000
701 701000000
661 661000000
Deferred income taxes - Note L
n/a
149 149000000
145 145000000
404 404000000
208 208000000
397 397000000
110 110000000
85 85000000
Other liabilities - Note J
n/a
590 590000000
575 575000000
691 691000000
633 633000000
520 520000000
460 460000000
405 405000000
Held for sale - Note B
n/a
0 0
0 0
0 0
0 0
99 99000000
0 0
0 0
Total Noncurrent Liabilities
n/a
4,446 4446000000
4,036 4036000000
7,092 7092000000
6,582 6582000000
5,808 5808000000
5,650 5650000000
5,575 5575000000
Commitments and contingencies - Notes K and N
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
1 1000000
1 1000000
1 1000000
1 1000000
1 1000000
1 1000000
0 0
Paid-in capital
n/a
521 521000000
665 665000000
627 627000000
647 647000000
506 506000000
0 0
0 0
Retained earnings
n/a
3,185 3185000000
2,837 2837000000
3,200 3200000000
3,163 3163000000
3,758 3758000000
3,475 3475000000
0 0
Accumulated other comprehensive income (loss)
n/a
-123 -123000000
304 304000000
307 307000000
218 218000000
288 288000000
107 107000000
0 0
Total stockholders' equity
n/a
3,584 3584000000
3,807 3807000000
4,135 4135000000
4,029 4029000000
4,553 4553000000
3,583 3583000000
3,037 3037000000
Total liabilities and stockholders' equity
n/a
9,607 9607000000
9,530 9530000000
12,966 12966000000
12,524 12524000000
12,088 12088000000
10,920 10920000000
10,054 10054000000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 23, 2011 n/a restated on Nov 19, 2012 n/a restated on Nov 27, 2013 n/a restated on Nov 24, 2014 n/a restated on Nov 20, 2015 n/a restated on Aug 8, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (53 items missing)
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net income
167
-261
141
414
26
683
233
309
Income from discontinued operations (net of tax)
8
21
-53
-358
-12
-130
-161
-118
Depreciation and amortization
145
305
280
299
359
356
393
341
Debt issuance cost amortization
0
52
81
26
54
65
14
18
Purchased in-process research and development impairment
0
10
0
0
0
0
0
0
Deferred income taxes
44
-123
-67
-57
-125
153
-294
-57
Equity income from affiliates
-23
-14
-19
-17
-34
-26
-25
-15
Distributions from equity affiliates
13
15
17
5
2
11
14
22
Gain from sale of property and equipment
-2
-2
-4
-2
0
0
0
0
Stock-based compensation expense - Note P
12
9
14
16
28
30
34
30
Stock contributions to qualified savings plans
0
13
22
13
0
0
0
0
Business Combination Loss On Derivatives
0
54
0
0
0
0
0
0
Loss (gain) on auction rate securities
0
32
0
0
0
0
0
0
Loss on early retirement of debt
0
1
0
0
0
0
0
9
Gain on available-for-sale securities
0
0
0
0
0
0
0
-3
Net loss (gain) on divestitures - Note B
-20
-59
-21
5
7
8
-4
115
Inventory fair value adjustment related to ISP acquisition
0
37
0
16
28
0
0
0
Impairments of equity method investment and in-process research and development
0
0
0
0
13
41
63
25
Pension contributions
-25
-47
-62
-50
-166
-124
-38
-610
Losses on pension and other postretirement plan remeasurements
0
409
268
0
0
0
0
0
Other current and noncurrent liabilities
-59
209
-19
-393
-332
0
0
0
Losses (gains) on pension and postretirement plan remeasurement
0
0
0
318
406
-417
438
255
Change in operating assets and liabilities
134
236
-108
-435
-563
3
-87
-232
Total cash flows provided by operating activities from continuing operations
478
735
551
243
189
653
580
89
Additions to property, plant and equipment
-205
-165
-192
-201
-242
-264
-248
-265
Proceeds from disposal of property, plant, and equpment
10
45
21
14
6
5
3
3
Purchase of operations - net of cash acquired
-129
-2,080
-23
-2,002
0
0
0
-13
Proceeds from sale of operations or equity investments
26
114
64
76
21
-13
92
161
Proceeds from Sale of Available-for-sale Securities
315
0
150
11
10
0
0
315
Settlement Currency Swap Acquisition
0
-95
0
0
0
0
0
0
Purchase of available-for-sale securities
-435
73
0
0
0
0
0
-315
Funds restricted for specific transactions
0
0
0
0
0
0
-15
-320
Reimbursement from restricted investments
0
0
0
0
0
0
0
6
Proceeds from the settlement of derivative instruments
0
0
0
0
0
0
0
18
Payments for the settlement of derivative instruments
0
0
0
0
0
0
0
-7
Total cash flows used by investing activities from continuing operations
-418
-2,108
20
-2,102
-205
-272
-168
-417
Proceeds from issuance of long-term debt
0
2,628
334
2,910
502
2,320
0
1,100
Repayment of long-term debt
-5
-1,862
-780
-1,513
-1,023
-2,613
-11
-623
Premium on long-term debt repayment
0
0
0
0
0
0
0
-9
Proceeds (repayment) from short-term debt
0
-19
48
12
261
-36
22
-3
Repurchase of common stock
0
0
0
-71
0
-150
-954
-397
Debt issuance costs
0
-162
-13
-82
-10
-38
0
-9
Cash dividends paid
-69
-22
-35
-51
-63
-88
-103
-98
Excess tax benefits related to share-based payments
1
1
5
4
16
13
12
9
Proceeds from exercise of stock options
3
9
6
3
0
0
0
0
Total cash flows used by financing activities from continuing operations
-70
573
-435
1,212
-317
-592
-1,034
-30
Cash used by continuing operations
-10
-800
136
-647
-333
-211
-622
-358
Operating cash flows
-8
290
-45
2
165
80
63
245
Investing cash flows
0
-7
-16
955
-37
-48
1,608
24
Total cash provided by discontinued operations
0
0
0
0
128
32
1,671
269
Effect of currency exchange rate changes on cash and cash equivalents
7
-17
-10
10
-9
2
-2
-47
Increase (decrease) in cash and cash equivalents
-11
-534
65
320
-214
-177
1,047
-136
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 19, 2012 n/a
calculated values,
restated on Nov 27, 2013 n/a
calculated values,
restated on Nov 24, 2014 n/a
calculated values,
restated on Nov 20, 2015 n/a
calculated values,
restated on Nov 20, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo